Werewolf Therapeutics, Inc.
HOWL
$0.7998
-$0.0702-8.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.09M | -20.40M | -16.67M | -17.25M | -16.19M |
| Total Depreciation and Amortization | 426.00K | 442.00K | 454.00K | 454.00K | 464.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.51M | 2.66M | 2.53M | 2.03M | 2.77M |
| Change in Net Operating Assets | -3.80M | 3.05M | 1.23M | 589.00K | -2.34M |
| Cash from Operations | -18.95M | -14.25M | -12.46M | -14.18M | -15.30M |
| Capital Expenditure | -- | -123.00K | -3.00K | -17.00K | -111.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -123.00K | -3.00K | -17.00K | -111.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 30.00M | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -40.00M | -- |
| Issuance of Common Stock | -- | 2.55M | -- | 953.00K | 20.26M |
| Repurchase of Common Stock | -- | -- | -6.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -673.00K | -- |
| Cash from Financing | -- | 2.55M | -6.00K | -9.72M | 20.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.95M | -11.83M | -12.47M | -23.91M | 4.85M |